Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Patent
1995-10-03
1999-04-27
Wityshyn, Michael G.
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
424 934, 4241841, 4242821, A01N 6300, A61K 3938, A61K 4500, C12N 120
Patent
active
058974750
ABSTRACT:
Methods using in vitro processes are disclosed for inducing or enhancing expression of enteric bacterial antigens or virulence factors. The methods, therefore, produce antigenically enhanced enteric bacteria. Also methods for using the antigenically enhanced bacteria are also disclosed, as well as vaccines containing the enteric bacteria. Specifically, a whole enteric bacteria or components thereof are provided by Helicobacter species. Also there are other enteric bacteria which are useful for the disclosed invention; such as Campylobacter jejuni.
REFERENCES:
patent: 5459041 (1995-10-01), Blaser
Andrews & Maurelli, 1992, "mxiA of Shigella flexneri 2a, which facilitates export of invasion plasmid antigens, encodes a homolog of the low-calcium-response protein, LcrD, of Yersinia pestis." Infect. Immun. 60:3287-3295.
Baqar et al., 1995, "Immunogenicity and protective efficacy of a prototype Campylobacter Killed whole-cell vaccine in mice." Infect. Immun. 63:3731-3735.
Bell & Manning, 1990, "A domestic ferret model of immunity to Campylobacter jejuni- induced enteric disease." Infect. Immun. 58:1848-1852.
Blaser & Gotschilch, 1990, "Surface array protein of Campylobacter fetus." J. Biol. Chem. 265:14529-14535.
Caldwell et al., 1983, "Simple adult rabbit model for Campylobacter jejuni enteritis." Infect. Immun. 42:1176-1182.
Chen et al., 1992, "Immunization against gastric helicobacter infection in a mouse/Helicobacter felis model." Lancet 339:1120-1121.
Durham et al., 1994, 94th Am. Soc. Microbiol. Abstract P-96, p. 386.
Field et al., 1993, "Characteristics of an avirulent Campylobacter jejuni strain and its virulence-enhanced variants." J. Med. Microbiol. 38:293-300.
Gilmour et al., 1991, "Vaccine containing iron-regulated proteins of Pasteurella haemolytica A2 enhances protection against experimental pasteurellosis in lambs." Vaccine 9:137-140.
Grant et al., 1993, "Role of flagella in adherence, internalization, and translocation of Campylobacter jejuni in nonpolarized and plarized epithelial cell cultures." Infect. Immun. 61:1764-1771.
Hale et al., 1985, "Identification and antigenic characterization of virulence-associated, plasmid-coded proteins of Shigella spp. and enteroinvasive Escherichia coli." Infect. Immun. 50:620-629.
High et al., 1992, "IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole." Embo J. 11:1991-1999.
Konkel et al., 1993, J. Infect. Dis. 168:948-954.
Levenson et al., 1988, "Parental immunization with Shigella ribosomal vaccine elicits local Ig A response and primes for mucosal memory." Arch. Allergy Appl. Immunol. 87:25-31.
J. Mekalanos, 1992, J. Bacteriol. 174:1-7.
Panigrahi et al., 1992, Infect. Immun. 60:4938-4944.
Pavlovskis et al., 1992, "Significance of flagella in colonization resistence of rabbits immunized with Campylobacter spp . . . " Infect. Immun. 59:2259-2264.
S.M. Payne, 1989, Mol. MicroBiol. 3:1301-1306.
Payne & Finkelstein, 1977, "Imferon agar: Improved medium for isolation of pathogenic Nesseria." J. Clin. Microbiol. 6:293-297.
Pope & Payne, 1993, 93rd Am. Soc. Microbiol. Abstract B-147.
Robbins et al., 1991, "O-Specific side-chain toxin-protein conjugates as parentaeral vaccines for the prevention of shigellosis and related diseases." Rev. Inf. Dis. 13:S362-365.
H.W. Yoder, 1989, "Congo red binding by Escherichia coli isolates from chickens." Avian Dis. 33:502-505.
Czinn and Nedrud, 1991, Infection and Immunity 59:2359-2363.
Frey Steven Michael
Pace John Lee
Walker Richard Ives
Antex Biologics Inc.
Ware Deborah
Wityshyn Michael G.
LandOfFree
Vaccines comprising enhanced antigenic helicobacter spp. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines comprising enhanced antigenic helicobacter spp., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines comprising enhanced antigenic helicobacter spp. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-681953